EE40 Cost-Effectiveness of GLP-1 Receptor Agonists Versus Long-Acting Insulins in Type 2 Diabetes From the Healthcare Sector Perspective: A Model-Based Analysis Using Real-World Data

Saved in:
Bibliographic Details
Published in:Value in health 2022-12, Vol.25 (12), p.S60-S61
Main Authors: Yao, WY, Yang, CT, Ou, HT, Kuo, S
Format: Article
Language:English
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:
ISSN:1098-3015
1524-4733
DOI:10.1016/j.jval.2022.09.293